NR4A1 and breast cancer: Approximately 70% of all breast cancers are hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer [2], which most frequently metastasizes to bone (59%), lung (22%), and liver (15%) [3].